Bulletin
Investor Alert

London Markets Open in:

Healthpeak Properties Inc.

NYS: PEAK

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Nov 25, 2022, 1:15 p.m.

/zigman2/quotes/205497622/composite

$

25.46

Change

0.00 0.00%

Volume

Volume 35,584

Quotes are delayed by 20 min

/zigman2/quotes/205497622/composite

Previous close

$ 25.26

$ 25.46

Change

+0.20 +0.79%

Day low

Day high

$25.26

$25.50

Open

52 week low

52 week high

$21.41

$36.85

Open

Company Description

Healthpeak Properties, Inc. is a real estate investment trust, which invests primarily in real estate serving the healthcare industry in the United States. It acquires, develops, leases, sells, and manages healthcare real estate and provides mortgage and other financing to healthcare providers. It o...

Healthpeak Properties, Inc. is a real estate investment trust, which invests primarily in real estate serving the healthcare industry in the United States. It acquires, develops, leases, sells, and manages healthcare real estate and provides mortgage and other financing to healthcare providers. It operates through the following business segments: Life Science, Medical Office and Continuing Care Retirement Community (CCRC). The Life Science segment contains laboratory and office space primarily for biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. The Medical Office segment includes pharmacies, hospital ancillary service space, and outpatient services such as diagnostic centers, rehabilitation clinics, and day-surgery operating rooms. The CCRC segment includes independent living, assisted living, and skilled nursing units to provide a continuum of care in an integrated campus. The company was founded in March 1985 and is headquartered in Denver, CO.

Valuation

P/E Current

155.58

P/E Ratio (with extraordinary items)

26.87

P/E Ratio (without extraordinary items)

222.23

Price to Sales Ratio

10.26

Price to Book Ratio

2.99

Price to Cash Flow Ratio

23.37

Enterprise Value to EBITDA

19.89

Enterprise Value to Sales

9.86

Efficiency

Total Asset Turnover

0.12

Profitability

Gross Margin

23.13

Operating Margin

16.73

Pretax Margin

6.77

Net Margin

6.15

Return on Assets

0.75

Return on Equity

1.75

Return on Total Capital

2.29

Capital Structure

Total Debt to Total Assets

42.94

Officers and Executives

Name Age Officer Since Title
Mr. Scott M. Brinker 42 2018 President & Chief Investment Officer
Mr. Thomas M. Klaritch 61 2003 Executive Vice President-Medical Office Properties
Mr. Peter A. Scott 39 2017 Chief Financial Officer & Executive Vice President
Mr. Keith Bereskin - 2013 SVP-Information Technology & Building Operations
Mr. Adam G. Mabry - 2017 Vice President-Corporate Transactions

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
10/03/2022 Troy E. McHenry
CLO and GC
3,822   Derivative/Non-derivative trans. at $22.92 per share. 87,600
10/03/2022 Lisa A. Alonso
EVP and Chief HR Officer
1,031   Derivative/Non-derivative trans. at $22.92 per share. 23,630
08/16/2022 Christine N. Garvey
Director
302   Gift at $0 per share. 0
05/23/2022 Christine N. Garvey
Director
102   Gift at $0 per share. 0
05/15/2022 Peter A. Scott
CFO
8,118   Derivative/Non-derivative trans. at $30.08 per share. 244,189
05/04/2022 Christine N. Garvey
Director
152   Gift at $0 per share. 0
04/28/2022 David B. Henry
Director
5,258   Award at $0 per share. 0
04/28/2022 R. Kent Griffin
Director
5,258   Award at $0 per share. 0
04/28/2022 Brian G. Cartwright
Director
5,258   Award at $0 per share. 0
04/28/2022 Christine N. Garvey
Director
5,258   Award at $0 per share. 0
04/28/2022 Lydia H. Kennard
Director
5,258   Award at $0 per share. 0
04/28/2022 Katherine Mary Sandstrom
Director
5,258   Award at $0 per share. 0
04/28/2022 Sara Grootwassink Lewis
Director
5,258   Award at $0 per share. 0
02/23/2022 Christine N. Garvey
Director
190   Gift at $0 per share. 0
02/15/2022 Thomas M. Herzog
CEO; Director
11,671   Derivative/Non-derivative trans. at $32.1 per share. 374,639
02/15/2022 Thomas M. Klaritch
COO
2,613   Derivative/Non-derivative trans. at $32.1 per share. 83,877
02/15/2022 Scott M. Brinker
President and CIO
3,855   Derivative/Non-derivative trans. at $32.1 per share. 123,745
02/15/2022 Peter A. Scott
CFO
3,221   Derivative/Non-derivative trans. at $32.1 per share. 103,394
02/15/2022 Troy E. McHenry
CLO and GC
2,009   Derivative/Non-derivative trans. at $32.1 per share. 64,488
02/15/2022 Jeffrey H. Miller
EVP - Development
1,740   Derivative/Non-derivative trans. at $32.1 per share. 55,854
02/15/2022 Shawn G. Johnston
EVP and CAO
897   Derivative/Non-derivative trans. at $32.1 per share. 28,793
02/15/2022 Scott Bohn
EVP, Co-Head of Life Science
561   Derivative/Non-derivative trans. at $32.1 per share. 18,008
02/15/2022 Lisa A. Alonso
EVP and Chief HR Officer
718   Derivative/Non-derivative trans. at $32.1 per share. 23,047
02/14/2022 Thomas M. Herzog
CEO; Director
11,672   Derivative/Non-derivative trans. at $32.45 per share. 378,756
02/14/2022 Thomas M. Klaritch
COO
2,116   Derivative/Non-derivative trans. at $32.45 per share. 68,664
02/14/2022 Scott M. Brinker
President and CIO
4,064   Derivative/Non-derivative trans. at $32.45 per share. 131,876
02/14/2022 Peter A. Scott
CFO
2,716   Derivative/Non-derivative trans. at $32.45 per share. 88,134
02/14/2022 Troy E. McHenry
CLO and GC
1,815   Derivative/Non-derivative trans. at $32.45 per share. 58,896
02/14/2022 Jeffrey H. Miller
EVP - Development
786   Derivative/Non-derivative trans. at $32.45 per share. 25,505
02/14/2022 Shawn G. Johnston
EVP and CAO
817   Derivative/Non-derivative trans. at $32.45 per share. 26,511
02/14/2022 Scott Bohn
EVP, Co-Head of Life Science
570   Derivative/Non-derivative trans. at $32.45 per share. 18,496
02/14/2022 Lisa A. Alonso
EVP and Chief HR Officer
322   Derivative/Non-derivative trans. at $32.45 per share. 10,448
02/12/2022 Thomas M. Herzog
CEO; Director
13,243   Derivative/Non-derivative trans. at $32.45 per share. 429,735
02/12/2022 Thomas M. Klaritch
COO
2,544   Derivative/Non-derivative trans. at $32.45 per share. 82,552
02/12/2022 Scott M. Brinker
President and CIO
5,084   Derivative/Non-derivative trans. at $32.45 per share. 164,975
02/12/2022 Peter A. Scott
CFO
3,028   Derivative/Non-derivative trans. at $32.45 per share. 98,258
02/12/2022 Troy E. McHenry
CLO and GC
1,987   Derivative/Non-derivative trans. at $32.45 per share. 64,478
02/12/2022 Jeffrey H. Miller
EVP - Development
893   Derivative/Non-derivative trans. at $32.45 per share. 28,977
02/12/2022 Shawn G. Johnston
EVP and CAO
921   Derivative/Non-derivative trans. at $32.45 per share. 29,886
02/12/2022 Scott Bohn
EVP, Co-Head of Life Science
1,704   Derivative/Non-derivative trans. at $32.45 per share. 55,294
02/12/2022 Lisa A. Alonso
EVP and Chief HR Officer
420   Derivative/Non-derivative trans. at $32.45 per share. 13,629
/news/latest/company/us/peak

MarketWatch News on PEAK

  1. Welltower Inc. stock rises Wednesday, outperforms market

    5:31 p.m. Nov. 23, 2022

    - MarketWatch Automation

  2. Ventas Inc. stock rises Wednesday, still underperforms market

    5:30 p.m. Nov. 23, 2022

    - MarketWatch Automation

  3. Healthpeak Properties Inc. stock falls Wednesday, underperforms market

    5:16 p.m. Nov. 23, 2022

    - MarketWatch Automation

  4. Ventas Inc. stock outperforms competitors on strong trading day

    5:30 p.m. Nov. 22, 2022

    - MarketWatch Automation

  5. Welltower Inc. stock rises Tuesday, still underperforms market

    5:30 p.m. Nov. 22, 2022

    - MarketWatch Automation

  6. Healthpeak Properties Inc. stock rises Tuesday, still underperforms market

    5:15 p.m. Nov. 22, 2022

    - MarketWatch Automation

  7. Welltower Inc. stock outperforms competitors on strong trading day

    5:30 p.m. Nov. 21, 2022

    - MarketWatch Automation

  8. Ventas Inc. stock outperforms market on strong trading day

    5:29 p.m. Nov. 21, 2022

    - MarketWatch Automation

  9. Healthpeak Properties Inc. stock rises Monday, outperforms market

    5:15 p.m. Nov. 21, 2022

    - MarketWatch Automation

  10. Welltower Inc. stock outperforms market on strong trading day

    5:30 p.m. Nov. 18, 2022

    - MarketWatch Automation

  11. Ventas Inc. stock rises Friday, outperforms market

    5:29 p.m. Nov. 18, 2022

    - MarketWatch Automation

  12. Healthpeak Properties Inc. stock rises Friday, outperforms market

    5:15 p.m. Nov. 18, 2022

    - MarketWatch Automation

  13. Welltower Inc. stock falls Thursday, underperforms market

    5:30 p.m. Nov. 17, 2022

    - MarketWatch Automation

  14. Ventas Inc. stock falls Thursday, underperforms market

    5:29 p.m. Nov. 17, 2022

    - MarketWatch Automation

  15. Welltower Inc. stock falls Wednesday, underperforms market

    5:30 p.m. Nov. 16, 2022

    - MarketWatch Automation

  16. Ventas Inc. stock underperforms Wednesday when compared to competitors

    5:29 p.m. Nov. 16, 2022

    - MarketWatch Automation

  17. Loading more headlines...
/news/nonmarketwatch/company/us/peak

Other News on PEAK

  1. Ventas' (VTR) Q3 FFO Meets, Revenues Beat, SHOP NOI Rises

    11:17 a.m. Nov. 4, 2022

    - Zacks.com

  2. Rayonier's (RYN) Q3 Earnings Beat Estimates, Revenues Lag

    10:21 a.m. Nov. 3, 2022

    - Zacks.com

  3. Healthpeak (PEAK) Meets Q3 FFO Estimates

    5:45 p.m. Nov. 1, 2022

    - Zacks.com

  4. Medical Properties Trust: The Current Situation Is Insane

    12:21 a.m. Oct. 12, 2022

    - Seeking Alpha

  5. Healthpeak Properties names investment chief Brinker as CEO

    4:42 p.m. Oct. 6, 2022

    - Seeking Alpha

  6. Loading more headlines...

At a Glance

Healthpeak Properties, Inc.

5050 South Syracuse Street

Suite 800

Denver, Colorado 80237-5050

Phone

1 9494070700

Industry

Healthcare REITs

Sector

Real Estate/Construction

Fiscal Year-end

12/2022

Revenue

$1.90B

Net Income

$116.61M

Employees

196.00

/news/pressrelease/company/us/peak

Press Releases on PEAK

  1. Healthpeak Properties Reports Third Quarter 2022 Results

    3:15 p.m. Nov. 1, 2022

    - PR Newswire - PRF

  2. Healthpeak Properties Announces Changes to Executive Team

    3:36 p.m. Oct. 6, 2022

    - PR Newswire - PRF

  3. Healthpeak Properties Reports Second Quarter 2022 Results

    3:15 p.m. Aug. 2, 2022

    - PR Newswire - PRF

  4. Healthpeak Properties Publishes its 11th Annual ESG Report

    5:55 p.m. July 19, 2022

    - PR Newswire - PRF

  5. Healthpeak Properties Reports First Quarter 2022 Results

    3:15 p.m. May 3, 2022

    - PR Newswire - PRF

  6. Healthpeak Properties Declares Quarterly Cash Dividend on Common Stock

    3:15 p.m. April 28, 2022

    - PR Newswire - PRF

  7. Healthpeak Reports Fourth Quarter and Year Ended 2021 Results

    4:15 p.m. Feb. 8, 2022

    - PR Newswire - PRF

  8. Loading more headlines...
Link to MarketWatch's Slice.